University of Hertfordshire

From the same journal

From the same journal

By the same authors

Meeting commentary-"Parkinson's disease: From patient to product"

Research output: Contribution to journalArticle

  • John Wahlich
  • David Elder
  • Fang Liu
  • Carmel Hughes
  • Mine Orlu-Gul
View graph of relations
Original languageEnglish
Article number15078
Number of pages5
Pages (from-to)167-171
JournalInternational Journal of Pharmaceutics
Journal publication date15 Oct 2015
Volume494
Issue1
Early online date3 Aug 2015
DOIs
Publication statusPublished - 15 Oct 2015

Abstract

A meeting organised by the Academy of Pharmaceutical Sciences (APSGB) Age-Related Medicines Focus Group took place on the 19th of May 2015, in GlaxoSmithKline Ware, UK [∗]. The meeting was the first of a planned series of disease specific meetings organised by APSGB. It was attended by a number of experts involved with the treatment and development of drugs for the older adult, including clinicians, pharmacists, academics, regulators and representatives from industry. The event created the platform to discuss the provision of medicines for the treatment of Parkinson's disease (PD) from a pharmaceutical sciences perspective. 'Medications are something you prescribe: something that gives me my life back' (A PD sufferer).

Notes

John Wahlich, et al, 'Meeting commentary–“Parkinson’s disease: From patient to product”', International Journal of Pharmaceutics, Vol. 494 (1): 167-171, October 2015, doi: https://doi.org/10.1016/j.ijpharm.2015.07.074.

ID: 9996711